Preventing chemotherapy‐induced alopecia in cancer patients: is scalp cooling worthwhile?
- 1 May 1987
- journal article
- Published by Wiley in Journal of Advanced Nursing
- Vol. 12 (3) , 303-310
- https://doi.org/10.1111/j.1365-2648.1987.tb01336.x
Abstract
Alopecia (hair loss) is often singled out as the most distressing side-effect of cancer chemotherapy treatment. This paper provides a comprehensive and critical review of the research literature on scalp cooling, a procedure introduced to prevent chemotherapy-induced alopecia. In spite of a considerable amount of research (both nursing and medical) over a 15-year period, the evidence on scalp cooling is inconclusive. Although concerned with a specialist issue, this paper may interest the general reader as it illustrates the value of a literature review in raising questions about current practice and in identifying issues for future research.Keywords
This publication has 27 references indexed in Scilit:
- AlopeciaCancer Nursing, 1984
- Prevention of doxorubicin-induced alopecia by scalp cooling in patients with advanced breast cancer.BMJ, 1981
- Alopecia and ChemotherapyThe American Journal of Nursing, 1980
- Scalp Tourniquets for Chemotherapy-Induced AlopeciaThe American Journal of Nursing, 1980
- INFLUENCE OF SCALP HYPOTHERMIA ON DOXORUBICIN RELATED ALOPECIAThe Lancet, 1980
- Prevention of Doxorubicin-Induced Hair Loss with Scalp HypothermiaNew England Journal of Medicine, 1979
- Body image and patients experiencing alopecia as a result of cancer chemotherapyCancer Nursing, 1979
- Scalp Tourniquet in the Prevention of Chemotherapy-Induced AlopeciaNew England Journal of Medicine, 1978
- PREVENTION OF HAIR LOSS BY HEAD-BAND DURING CYTOTOXIC THERAPYThe Lancet, 1974
- DRUG REACTIONS XXIII.British Journal of Dermatology, 1973